Encourage Medical Programs, Inc. (INSP) Presents at UBS World Healthcare Convention 2025 Transcript

Danielle Antalffy
UBS Funding Financial institution, Analysis Division

All proper. Good morning, everybody. Thanks a lot for becoming a member of us. I am Danielle Antalffy, the U.S. med tech analyst for UBS. Very fortunate to have with us Encourage Medical Programs, Tim Herbert, President and CEO; Ezgi Yagci, Head of Investor Relations. So guys, thanks for becoming a member of.

Timothy Herbert
Founder, Chairman, CEO & President

Danielle, thanks for having us. It is so nice to be right here.

Danielle Antalffy
UBS Funding Financial institution, Analysis Division

And I suppose place to begin. You probably did simply report earnings, you had quarter. So possibly just a few fast hits on the quarter and a few of the drivers after which we will dig into Q&A.

Timothy Herbert
Founder, Chairman, CEO & President

It was a vital quarter for us to report again, and there is a lot stress that we had after the top of the second quarter, that was fairly a difficult quarter for us, working via the transition from Encourage IV to our next-generation Encourage V system. We made great progress with that through the third quarter, had an excellent pickup that confirmed with our outcomes as nicely. However most significantly is we’re capable of report the affected person outcomes related to the brand new system, Encourage V, each in a scientific research that we ran in Singapore in addition to the primary industrial expertise right here in the USA. And that final result state is so sturdy, and it actually units us up transferring ahead. We did work via fairly a little bit of the transition within the third quarter, getting the